Literature DB >> 26041379

Gross classification of solitary small hepatocellular carcinoma on preoperative computed tomography: Prognostic significance after radiofrequency ablation.

Xu Fu1, Liang Mao1, Min Tang2, Xiaopeng Yan1, Yudong Qiu1, Jian He2, Tie Zhou1.   

Abstract

AIM: The prognostic significance of the gross classification of hepatocellular carcinoma (HCC) has been confirmed in both hepatectomy and living donor liver transplantation. However, the role of this type of classification in HCC treated with radiofrequency ablation (RFA) has rarely been reported. The aim of this study was to investigate the role of preoperative gross classification in cases of solitary small HCC treated with RFA.
METHODS: From January 2007 to September 2013, 103 patients with solitary small HCC treated with RFA were retrospectively reviewed. The lesions were classified into three types according to gross appearance in preoperative contrast-enhanced computed tomography (CT) scans. Clinicopathological variables and survival information were compared among these three types. Univariate and multivariate analyses were performed to clarify the long-term prognostic factors.
RESULTS: The group of 103 tumors comprised 34 type 1, 49 type 2 and 20 type 3 tumors. The level of preoperative serum α-fetoprotein in the type 3 tumors was significantly higher than that in types 1 and 2 (P < 0.05). The overall survival of the patients with type 3 HCC was the poorest among the three types. The tumor-free survival of the patients with types 3 and 2 HCC were significantly poorer than those with type 1 (P < 0.05). The univariate analysis showed that gross classification, α-fetoprotein level, tumor size and degree of enhancement were poor prognostic factors. The multivariate analysis indicated that the gross classification was the only independent prognostic indicator.
CONCLUSION: The preoperative gross classification was of great prognostic significance in solitary small HCC treated with RFA.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  ablation techniques; carcinoma; classification; hepatocellular carcinoma; multidetector computed tomography; prognosis

Year:  2015        PMID: 26041379     DOI: 10.1111/hepr.12540

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

1.  Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.

Authors:  Xiaopeng Yan; Xu Fu; Min Deng; Jun Chen; Jian He; Jiong Shi; Yudong Qiu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

2.  The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma.

Authors:  Yangkyu Lee; Hyunjin Park; Hyejung Lee; Jai Young Cho; Yoo-Seok Yoon; Young-Rok Choi; Ho-Seong Han; Eun Sun Jang; Jin-Wook Kim; Sook-Hyang Jeong; Soomin Ahn; Haeryoung Kim
Journal:  J Pathol Transl Med       Date:  2017-11-24

3.  Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.

Authors:  Chuang Chen; Hui Zhao; Xu Fu; LuoShun Huang; Min Tang; XiaoPeng Yan; ShiQuan Sun; WenJun Jia; Liang Mao; Jiong Shi; Jun Chen; Jian He; Jin Zhu; YuDong Qiu
Journal:  Oncotarget       Date:  2017-05-02

4.  Prognostic value of computed tomography characteristics for overall survival in patients with maxillary cancer.

Authors:  Ying Yuan; Jingbo Wang; Yingwei Wu; Guojun Li; Xiaofeng Tao
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

Review 5.  Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.

Authors:  Archana Rastogi
Journal:  World J Gastroenterol       Date:  2018-09-21       Impact factor: 5.742

6.  The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy.

Authors:  Jian He; Jiong Shi; Xu Fu; Liang Mao; Tie Zhou; Yudong Qiu; Bin Zhu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.